| Year |
Citation |
Score |
| 2020 |
Ramalingam P, Poulos MG, Lazzari E, Gutkin MC, Lopez D, Kloss CC, Crowley MJ, Katsnelson L, Freire AG, Greenblatt MB, Park CY, Butler JM. Chronic activation of endothelial MAPK disrupts hematopoiesis via NFKB dependent inflammatory stress reversible by SCGF. Nature Communications. 11: 666. PMID 32015345 DOI: 10.1038/S41467-020-14478-8 |
0.408 |
|
| 2018 |
Castellarin M, Watanabe K, June CH, Kloss CC, Posey AD. Driving cars to the clinic for solid tumors. Gene Therapy. PMID 29880908 DOI: 10.1038/S41434-018-0007-X |
0.302 |
|
| 2018 |
Wertheimer T, Velardi E, Tsai J, Cooper K, Xiao S, Kloss CC, Ottmüller KJ, Mokhtari Z, Brede C, deRoos P, Kinsella S, Palikuqi B, Ginsberg M, Young LF, Kreines F, et al. Production of BMP4 by endothelial cells is crucial for endogenous thymic regeneration. Science Immunology. 3. PMID 29330161 DOI: 10.1126/Sciimmunol.Aal2736 |
0.438 |
|
| 2015 |
Zhao Z, Condomines M, van der Stegen SJ, Perna F, Kloss CC, Gunset G, Plotkin J, Sadelain M. Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells. Cancer Cell. 28: 415-28. PMID 26461090 DOI: 10.1016/J.Ccell.2015.09.004 |
0.343 |
|
| 2015 |
Johnson LA, Scholler J, Ohkuri T, Kosaka A, Patel PR, McGettigan SE, Nace AK, Dentchev T, Thekkat P, Loew A, Boesteanu AC, Cogdill AP, Chen T, Fraietta JA, Kloss CC, et al. Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma. Science Translational Medicine. 7: 275ra22. PMID 25696001 DOI: 10.1126/Scitranslmed.Aaa4963 |
0.337 |
|
| 2014 |
Poulos MG, Gars EJ, Gutkin MC, Kloss CC, Ginsberg M, Scandura JM, Rafii S, Butler JM. Activation of the vascular niche supports leukemic progression and resistance to chemotherapy. Experimental Hematology. 42: 976-86.e1-3. PMID 25179751 DOI: 10.1016/J.Exphem.2014.08.003 |
0.423 |
|
| 2014 |
Fedorov VD, Sadelain M, Kloss CC. Novel approaches to enhance the specificity and safety of engineered T cells. Cancer Journal (Sudbury, Mass.). 20: 160-5. PMID 24667964 DOI: 10.1097/Ppo.0000000000000040 |
0.317 |
|
| 2014 |
Wertheimer T, Kloss CC, Velardi E, Brede C, Ginsberg M, Kreines FM, Zakrzewski JL, Tuckett AZ, Tsai JJ, Smith OM, Levy ER, Beilhack A, Rafii S, Butler JM, van den Brink MR, et al. Endothelial Cells Promote Endogenous Thymic Regeneration after Injury Via BMP4 Signaling Blood. 124: 2429-2429. DOI: 10.1182/Blood.V124.21.2429.2429 |
0.438 |
|
| 2013 |
Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gonen M, Sadelain M. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nature Biotechnology. 31: 928-33. PMID 23934177 DOI: 10.1038/Nbt.2678 |
0.397 |
|
| 2013 |
Davila ML, Kloss CC, Gunset G, Sadelain M. CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia. Plos One. 8: e61338. PMID 23585892 DOI: 10.1371/Journal.Pone.0061338 |
0.364 |
|
| 2013 |
Rafii S, Kloss CC, Butler JM, Ginsberg M, Gars E, Lis R, Zhan Q, Josipovic P, Ding BS, Xiang J, Elemento O, Zaninovic N, Rosenwaks Z, Sadelain M, Rafii JA, et al. Human ESC-derived hemogenic endothelial cells undergo distinct waves of endothelial to hematopoietic transition. Blood. 121: 770-80. PMID 23169780 DOI: 10.1182/Blood-2012-07-444208 |
0.447 |
|
| 2011 |
James D, Zhan Q, Kloss C, Zaninovic N, Rosenwaks Z, Rafii S. Lentiviral transduction and clonal selection of hESCs with endothelial-specific transgenic reporters. Current Protocols in Stem Cell Biology. Unit1F.12. PMID 21509935 DOI: 10.1002/9780470151808.Sc01F12S17 |
0.423 |
|
| Show low-probability matches. |